Protein networks in induced sputum from smokers and COPD patients

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1957-1975

  Baraniuk, James N ^a   Casado, Begona ^a   Pannell, Lewis K ^b   McGarvey, Peter B ^a   Boschetto, Piera ^c   Luisetti, Maurizio ^d   Iadarola, Paolo ^e  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chronic bronchitis; Cigarette smokers; Emphysema; Mucin 5AC; Mucous hypersecretion; Neutrophil extracellular nets; Proteomics

Indexed keywords

AMYLASE; AMYLASE 1A; CELL PROTEIN; DEFENSIN; HISTONE; IMMUNOGLOBULIN; MUCIN 5AC; PLASMA PROTEIN; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CELL HYPERPLASIA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOBLET CELL; HUMAN; LUNG EMPHYSEMA; MALE; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS; SMOKING; SPUTUM EXAMINATION; AGED; BLOOD; FORCED EXPIRATORY VOLUME; METABOLISM; MIDDLE AGED; MUCUS; PATHOPHYSIOLOGY; SECRETION (PROCESS); SPUTUM;

ADULT; AGED; BRONCHITIS, CHRONIC; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MALE; MIDDLE AGED; MUCIN 5AC; MUCUS; PROTEOMICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING; SPUTUM;

EID: 84942012291     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S75978     Document Type: Article

References (62)

1. Vestbo J. Chronic mucus hypersecretion, exacerbations and natural history of COPD. Exp Lung Res. 2005;31 Suppl 1:63-65.
2. Joos GF. Mechanisms of COPD. Exp Lung Res. 2005;31 Suppl 1: 66-71.
3. Omori H, Nakashima R, Otsuka N, et al. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology. 2006;11:205-210.
4. Nicholas B, Djukanovic R. Induced sputum: a window to lung pathology. Biochem Soc Trans. 2009;37:868-872.
5. Boschetto P, Quintavalle S, Zeni E, et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax. 2006;61:1037-1042.
6. Luisetti M, Ma S, Iadarola P, et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J. 2008;32:1146-1157.
7. Casado B, Iadarola P, Pannell LK, et al. Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J Proteome Res. 2007;6:4615-4623.
8. National Center for Biotechnology Information. BPIFB1: BPI fold containing family B, member 1 [Homo sapiens (human)]. 2015. Available from: http://www.ncbi.nlm.nih.gov/gene/92747. Accessed May 21, 2015.
9. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363:2233-2247.
10. Wartha F, Beiter K, Normark S, Henriques-Normark B. Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol. 2007;10:52-56.
11. von Köckritz-Blickwede M, Nizet V. Innate immunity turned insideout: antimicrobial defense by phagocyte extracellular traps. J Mol Med (Berl). 2009;87:775-783.
12. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176:231-241.
13. Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev. 2005; 206:83-99.
14. Richens JL, Urbanowicz RA, Lunt EA, et al. Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease. Respir Res. 2009; 10:29.
15. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care. 2009;54:1040-1049.
16. Protein Information Resource [homepage on the Internet]. Available from: http://pir.georgetown.edu/. Accessed May 21, 2015.
17. Huang H, McGarvey PB, Suzek BE, et al. A comprehensive protein-centric ID mapping service for molecular data integration. Bioinformatics. 2011;27:1190-1191.
18. ImMunoGeneTics [homepage on the Internet]. Available from: http:// www.imgt.org. Accessed May 21, 2015.
19. Li M, Gray W, Zhang H, et al. Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J Proteome Res. 2010;9:4295-4305.
20. Lui H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004;76:4193-4201.
21. Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol. 2005;1:252-262.
22. Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001;19:242-247.
23. Swinscow TD. Statistics at Square One. Oxford, UK: BMJ Books; 1980.
24. Campbell MJ. Statistics at Square Two: Understanding Modern Statistical Applications in Medicine. London: BMJ Books; 2001.
25. Barnett V, Lewis T. Outliers in Statistical Data. New York: John Wiley & Sons; 1994.
26. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27:431-432.
27. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-2504.
28. Reactome Wiki. Reactome FI Cytoscape Plugin 4. Available from: http://wiki.reactome.org/index.php/Reactome_FI_Cytoscape_Plugin. Accessed May 21, 2015.
29. Wu G, Feng X, Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 2010;11:R53.
30. Newman ME. Modularity and community structure in networks. Proc Natl Acad Sci U S A. 2006;103:8577-8582.
31. STRING [homepage on the Internet]. Available from: http://string-db. org. Accessed May 21, 2015.
32. Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: proteinprotein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808-D815.
33. KEGG: Kyoto Encyclopedia of Genes and Genomes [homepage on the Internet]. Available from: http://www.genome.jp/kegg. Accessed May 21, 2015.
34. BioCarta [homepage on the Internet]. Available from: http://www. biocarta.com. Accessed May 21, 2015.
35. Schaefer CF, Anthony K, Krupa S, et al. PID: the Pathway Interaction Database. Nucleic Acids Res. 2009;37:D674-D679.
36. Croft D, O’Kelly G, Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39: D691-D697.
37. Gohy ST, Detry BR, Lecocq M, et al. Polymeric immunoglobulin receptor down-regulation in chronic obstructive pulmonary disease. Persistence in the cultured epithelium and role of transforming growth factor-ß. Am J Respir Crit Care Med. 2014;190:509-521.
38. Hackett NR, Butler MW, Shaykhiev R, et al. RNA-Seq quantification of the human small airway epithelium transcriptome. BMC Genomics. 2012;13:82.
39. Steiling K, Kadar AY, Bergerat A, et al. Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS One. 2009;4:e5043.
40. Vanni H, Kazeros A, Wang R, et al. Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human. Chest. 2009;135: 1197-1208.
41. Boelens MC, van den Berg A, Fehrmann RS, et al. Current smokingspecific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer. J Pathol. 2009;218:182-191.
42. Sridhar S, Schembri F, Zeskind J, et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics. 2008;9:259.
43. Wang G, Xu Z, Wang R, et al. Genes associated with MUC5AC expression in small airway epithelium of human smokers and non-smokers. BMC Med Genomics. 2012;5:21.
44. Zhang LI, Lee J, Tang H, et al. Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers. Cancer Prev Res. 2008;1:112-118.
45. Barber MF, Elde NC. Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science. 2014;346: 1362-1366.
46. Ocejo-Garcia M, Baokbah TA, Ashurst HL, et al. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. J Pathol. 2005; 206:151-159.
47. Sato A, Xu Y, Whitsett JA, Ikegami M. CCAAT/enhancer binding protein-a regulates the protease/antiprotease balance required for bronchiolar epithelium regeneration. Am J Respir Cell Mol Biol. 2012;47: 454-463.
48. Sato A, Yamada N, Ogawa Y, Ikegami M. CCAAT/enhancer-binding protein-a suppresses lung tumor development in mice through the p38a MAP kinase pathway. PLoS One. 2013;8:e57013.
49. Hibi K, Liu Q, Beaudry GA, et al. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res. 1998;58:5690-5694.
50. Hong JS, Kim SW, Koo JS. Sp1 up-regulates cAMP-response-elementbinding protein expression during retinoic acid-induced mucous differentiation of normal human bronchial epithelial cells. Biochem J. 2008; 410:49-61.
51. Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:500-505.
52. Garcia-Caballero A, Rasmussen JE, Gaillard E, et al. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci U S A. 2009;106:11412-11417.
53. Bartlett JA, Hicks BJ, Schlomann JM, Ramachandran S, Nauseef WM, McCray PB Jr. PLUNC is a secreted product of neutrophil granules. J Leukoc Biol. 2008;83:1201-1206.
54. Gray RD, MacGregor G, Noble D, et al. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med. 2008;178:444-452.
55. Braido F, Riccio AM, Guerra L, et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med. 2007;101:2119-2124.
56. Merkel D, Rist W, Seither P, Weith A, Lenter MC. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics. 2005;5:2972-2980.
57. Sepper R, Prikk K. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res. 2004;3:277-281.
58. Lee EJ, In KH, Kim JH, et al. Proteomic analysis in lung tissue of smokers and COPD patients. Chest. 2009;135:344-352.
59. Ohlmeier S, Vuolanto M, Toljamo T, et al. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res. 2008;7:5125-5132.
60. Roth MJ, Forbes AJ, Boyne MT 2nd, KimYB, Robinson DE, Kelleher NL. Precise and parallel characterization of coding polymorphisms, alternative splicing, and modifications in human proteins by mass spectrometry. Mol Cell Proteomics. 2005;4:1002-1008.
61. Choi SM, Lee J, Park YS, et al. Prevalence and Global Initiative for Chronic Obstructive Lung Disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test. PLoS One. 2015;10:e0115787.
62. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347-365.